| Immune-correlates analysis of an HIV-1 vaccine efficacy trial BF Haynes, PB Gilbert, MJ McElrath, S Zolla-Pazner, GD Tomaras, ... New England Journal of Medicine 366 (14), 1275-1286, 2012 | 2085 | 2012 |
| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 914 | 2022 |
| Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination NL Yates, HX Liao, Y Fong, A DeCamp, NA Vandergrift, WT Williams, ... Science translational medicine 6 (228), 228ra39-228ra39, 2014 | 469 | 2014 |
| Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG GD Tomaras, G Ferrari, X Shen, SM Alam, HX Liao, J Pollara, ... Proceedings of the National Academy of Sciences 110 (22), 9019-9024, 2013 | 450 | 2013 |
| Bayesian inference for generalized linear mixed models Y Fong, H Rue, J Wakefield Biostatistics 11 (3), 397-412, 2010 | 347 | 2010 |
| Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection S Zolla-Pazner, A DeCamp, PB Gilbert, C Williams, NL Yates, ... PloS one 9 (2), e87572, 2014 | 293 | 2014 |
| Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape NI Mazur, J Terstappen, R Baral, A Bardají, P Beutels, UJ Buchholz, ... The Lancet Infectious Diseases 23 (1), e2-e21, 2023 | 192 | 2023 |
| MES-4: an autosome-associated histone methyltransferase that participates in silencing the X chromosomes in the C. elegans germ line LB Bender, J Suh, CR Carroll, Y Fong, IM Fingerman, SD Briggs, R Cao, ... Oxford University Press for The Company of Biologists Limited 133 (19), 3907 …, 2006 | 165 | 2006 |
| Regulation of the different chromatin states of autosomes and X chromosomes in the germ line of C. elegans Y Fong, L Bender, W Wang, S Strome Science 296 (5576), 2235-2238, 2002 | 163 | 2002 |
| A Covid-19 milestone attained—a correlate of protection for vaccines PB Gilbert, RO Donis, RA Koup, Y Fong, SA Plotkin, D Follmann New England Journal of Medicine 387 (24), 2203-2206, 2022 | 134 | 2022 |
| chngpt: Threshold regression model estimation and inference Y Fong, Y Huang, PB Gilbert, SR Permar BMC bioinformatics 18, 1-7, 2017 | 133 | 2017 |
| FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial SS Li, PB Gilbert, GD Tomaras, G Kijak, G Ferrari, R Thomas, CW Pyo, ... The Journal of clinical investigation 124 (9), 3879-3890, 2014 | 121 | 2014 |
| Clinical endpoints for evaluating efficacy in COVID-19 vaccine trials DV Mehrotra, HE Janes, TR Fleming, PW Annunziato, KM Neuzil, ... Annals of internal medicine 174 (2), 221-228, 2021 | 116 | 2021 |
| Fc characteristics mediate selective placental transfer of IgG in HIV-infected women DR Martinez, Y Fong, SH Li, F Yang, MF Jennewein, JA Weiner, ... Cell 178 (1), 190-201. e11, 2019 | 102 | 2019 |
| Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk SD Neidich, Y Fong, SS Li, DE Geraghty, BD Williamson, WC Young, ... The Journal of Clinical Investigation 129 (11), 4838-4849, 2019 | 101 | 2019 |
| The Caenorhabditis elegans maternal-effect sterile proteins, MES-2, MES-3, and MES-6, are associated in a complex in embryos L Xu, Y Fong, S Strome Proceedings of the National Academy of Sciences 98 (9), 5061-5066, 2001 | 99 | 2001 |
| Neutralizing antibody correlates analysis of tetravalent dengue vaccine efficacy trials in Asia and Latin America Z Moodie, M Juraska, Y Huang, Y Zhuang, Y Fong, LN Carpp, SG Self, ... The Journal of infectious diseases 217 (5), 742-753, 2018 | 94 | 2018 |
| Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding JT Schiffer, BT Mayer, Y Fong, DA Swan, A Wald Journal of The Royal Society Interface 11 (95), 20140160, 2014 | 87 | 2014 |
| Maternal HIV-1 envelope–specific antibody responses and reduced risk of perinatal transmission SR Permar, Y Fong, N Vandergrift, GG Fouda, P Gilbert, R Parks, ... The Journal of clinical investigation 125 (7), 2702-2706, 2015 | 83 | 2015 |
| Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection C Johnston, J Zhu, L Jing, KJ Laing, CM McClurkan, A Klock, K Diem, ... Journal of virology 88 (9), 4921-4931, 2014 | 74 | 2014 |
| Analysis of HLA A* 02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial AJ Gartland, S Li, J McNevin, GD Tomaras, R Gottardo, H Janes, Y Fong, ... Journal of virology 88 (15), 8242-8255, 2014 | 73 | 2014 |
| Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees P Liu, NL Yates, X Shen, M Bonsignori, MA Moody, HX Liao, Y Fong, ... Journal of virology 87 (14), 7828-7836, 2013 | 72 | 2013 |
| Significant patient impact observed upon implementation of point-of-care early infant diagnosis technologies in an observational study in Malawi R Mwenda, Y Fong, T Magombo, E Saka, D Midiani, C Mwase, J Kandulu, ... Clinical Infectious Diseases 67 (5), 701-707, 2018 | 69 | 2018 |
| Immune Assays Team § ; Moderna, Inc. Team § ; Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE) Team § ; United States Government (USG)/CoVPN … PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 65 | 2022 |
| Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1–serodiscordant couples EM Kahle, Partners in Prevention HSV/HIV Transmission Study Team, ... The Journal of infectious diseases 211 (9), 1451-1460, 2015 | 64 | 2015 |
| Correlates of protection, thresholds of protection, and immunobridging among persons with SARS-CoV-2 infection DS Khoury, TE Schlub, D Cromer, M Steain, Y Fong, PB Gilbert, ... Emerging Infectious Diseases 29 (2), 381, 2023 | 60 | 2023 |
| Immune correlates analysis of the ENSEMBLE single Ad26. COV2. S dose vaccine efficacy clinical trial Y Fong, AB McDermott, D Benkeser, S Roels, DJ Stieh, A Vandebosch, ... Nature microbiology 7 (12), 1996-2010, 2022 | 57 | 2022 |
| A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial … SC Murphy, ER Duke, KJ Shipman, RL Jensen, Y Fong, S Ferguson, ... The Journal of infectious diseases 217 (5), 693-702, 2018 | 57 | 2018 |
| HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition HA Prentice, GD Tomaras, DE Geraghty, R Apps, Y Fong, PK Ehrenberg, ... Science translational medicine 7 (296), 296ra112-296ra112, 2015 | 57 | 2015 |
| Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial Y Fong, Y Huang, D Benkeser, LN Carpp, G Áñez, W Woo, A McGarry, ... Nature communications 14 (1), 331, 2023 | 52 | 2023 |
| The inner foreskin of healthy males at risk of HIV infection harbors epithelial CD4+ CCR5+ cells and has features of an inflamed epidermal barrier MP Lemos, JR Lama, ST Karuna, Y Fong, SM Montano, C Ganoza, ... PloS one 9 (9), e108954, 2014 | 49 | 2014 |
| Improving random forest predictions in small datasets from two-phase sampling designs S Han, BD Williamson, Y Fong BMC medical informatics and decision making 21, 1-9, 2021 | 45 | 2021 |
| Nonlinear calibration model choice between the four and five-parameter logistic models WN Cumberland, Y Fong, X Yu, O Defawe, N Frahm, S De Rosa Journal of Biopharmaceutical Statistics 25 (5), 972-983, 2015 | 45 | 2015 |
| Optimization and qualification of a multiplex bead array to assess cytokine and chemokine production by vaccine-specific cells OD Defawe, Y Fong, E Vasilyeva, M Pickett, DK Carter, E Gabriel, ... Journal of immunological methods 382 (1-2), 117-128, 2012 | 41 | 2012 |
| Modification of the association between T-cell immune responses and human immunodeficiency virus type 1 infection risk by vaccine-induced antibody responses in the HVTN 505 trial Y Fong, X Shen, VC Ashley, A Deal, KE Seaton, C Yu, SP Grant, G Ferrari, ... The Journal of infectious diseases 217 (8), 1280-1288, 2018 | 40 | 2018 |
| Model-robust inference for continuous threshold regression models Y Fong, C Di, Y Huang, PB Gilbert Biometrics 73 (2), 452-462, 2017 | 38 | 2017 |
| HIV-exposed infants vaccinated with an MF59/recombinant gp120 vaccine have higher-magnitude anti-V1V2 IgG responses than adults immunized with the same vaccine EP McGuire, Y Fong, C Toote, CK Cunningham, EJ McFarland, ... Journal of virology 92 (1), 10.1128/jvi. 01070-17, 2018 | 37 | 2018 |
| HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy PB Gilbert, Y Fong, M Juraska, LN Carpp, AS Monto, ET Martin, JG Petrie BMC infectious diseases 19, 1-12, 2019 | 36 | 2019 |
| Change point testing in logistic regression models with interaction term Y Fong, C Di, S Permar Statistics in medicine 34 (9), 1483-1494, 2015 | 34 | 2015 |
| Modified wilcoxon–mann–whitney test and power against strong null Y Fong, Y Huang The American Statistician 73 (1), 43-49, 2019 | 32 | 2019 |
| Identifying optimal biomarker combinations for treatment selection via a robust kernel method Y Huang, Y Fong Biometrics 70 (4), 891-901, 2014 | 32 | 2014 |
| Fc gamma receptor polymorphisms modulated the vaccine effect on HIV-1 risk in the HVTN 505 HIV vaccine trial SS Li, PB Gilbert, LN Carpp, CW Pyo, H Janes, Y Fong, X Shen, ... Journal of Virology 93 (21), 10.1128/jvi. 02041-18, 2019 | 31 | 2019 |
| Combining biomarkers linearly and nonlinearly for classification using the area under the ROC curve Y Fong, S Yin, Y Huang Statistics in medicine 35 (21), 3792-3809, 2016 | 30 | 2016 |
| A robust Bayesian random effects model for nonlinear calibration problems Y Fong, J Wakefield, S De Rosa, N Frahm Biometrics 68 (4), 1103-1112, 2012 | 29 | 2012 |
| Performance of Cepheid Xpert HIV-1 viral load plasma assay to accurately detect treatment failure JA Sacks, Y Fong, MP Gonzalez, M Andreotti, S Baliga, N Garrett, ... Aids 33 (12), 1881-1889, 2019 | 28 | 2019 |
| Rank-based two-sample tests for paired data with missing values Y Fong, Y Huang, MP Lemos, MJ Mcelrath Biostatistics 19 (3), 281-294, 2018 | 27 | 2018 |
| Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination. Sci Transl Med 6: 228ra39 NL Yates, HX Liao, Y Fong, A DeCamp, NA Vandergrift, WT Williams, ... | 25 | 2014 |
| nCal: an R package for non-linear calibration Y Fong, K Sebestyen, X Yu, P Gilbert, S Self Bioinformatics 29 (20), 2653-2654, 2013 | 25 | 2013 |
| Vapour pressure deficit determines critical thresholds for global coffee production under climate change J Kath, A Craparo, Y Fong, V Byrareddy, AP Davis, R King, T Nguyen-Huy, ... Nature Food 3 (10), 871-880, 2022 | 23 | 2022 |
| Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans LP Zhao, A Fiore-Gartland, LN Carpp, KW Cohen, N Rouphael, L Fleurs, ... PloS one 15 (1), e0226803, 2020 | 20 | 2020 |
| Fast bootstrap confidence intervals for continuous threshold linear regression Y Fong Journal of Computational and Graphical Statistics 28 (2), 466-470, 2019 | 19 | 2019 |
| Bayesian inference and model choice in a hidden stochastic two-compartment model of hematopoietic stem cell fate decisions Y Fong, P Guttorp, J Abkowitz The annals of applied statistics 3 (4), 1696, 2009 | 19 | 2009 |
| A deferred-vaccination design to assess durability of COVID-19 vaccine effect after the placebo group is vaccinated D Follmann, J Fintzi, MP Fay, HE Janes, LR Baden, HM El Sahly, ... Annals of internal medicine 174 (8), 1118-1125, 2021 | 18 | 2021 |
| Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial D Benkeser, DC Montefiori, AB McDermott, Y Fong, HE Janes, W Deng, ... Science translational medicine 15 (692), eade9078, 2023 | 17 | 2023 |
| Proportions of CD4 test results indicating advanced HIV disease remain consistently high at primary health care facilities across four high HIV burden countries K Lamp, S McGovern, Y Fong, CD Atem, JBE Nfetam, D Nzuobontane, ... PLoS One 15 (1), e0226987, 2020 | 17 | 2020 |
| In men at risk of HIV infection, IgM, IgG1, IgG3, and IgA reach the human foreskin epidermis MP Lemos, ST Karuna, GJ Mize, Y Fong, SM Montano, C Ganoza, ... Mucosal immunology 9 (3), 798-808, 2016 | 17 | 2016 |
| The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysis R Luo, Y Fong, D Boeras, I Jani, L Vojnov The Lancet 400 (10356), 887-895, 2022 | 16 | 2022 |
| Estimation and inference for upper hinge regression models A Elder, Y Fong Environmental and ecological statistics 26, 287-302, 2019 | 16 | 2019 |
| Quality control, analysis and secure sharing of Luminex® immunoassay data using the open source LabKey Server platform J Eckels, C Nathe, EK Nelson, SG Shoemaker, EV Nostrand, NL Yates, ... BMC bioinformatics 14, 1-17, 2013 | 16 | 2013 |
| A controlled effects approach to assessing immune correlates of protection PB Gilbert, Y Fong, A Kenny, M Carone Biostatistics 24 (4), 850-865, 2023 | 14 | 2023 |
| Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine D Benkeser, Y Fong, HE Janes, EJ Kelly, I Hirsch, S Sproule, AM Stanley, ... npj Vaccines 8 (1), 36, 2023 | 14 | 2023 |
| Bridging efficacy of a tetravalent dengue vaccine from children/adolescents to adults in highly endemic countries based on neutralizing antibody response PB Gilbert, Y Huang, M Juraska, Z Moodie, Y Fong, A Luedtke, Y Zhuang, ... The American journal of tropical medicine and hygiene 101 (1), 164, 2019 | 14 | 2019 |
| Assessing durability of vaccine effect following blinded crossover in COVID-19 vaccine efficacy trials D Follmann, J Fintzi, MP Fay, HE Janes, L Baden, H El Sahly, TR Fleming, ... medRxiv, 2020 | 12 | 2020 |
| Efficacy of a bivalent killed whole-cell cholera vaccine over five years: a re-analysis of a cluster-randomized trial Y Fong, ME Halloran, JK Park, F Marks, JD Clemens, DL Chao BMC infectious diseases 18, 1-8, 2018 | 12 | 2018 |
| Fast grid search and bootstrap‐based inference for continuous two‐phase polynomial regression models H Son, Y Fong Environmetrics 32 (3), e2664, 2021 | 11 | 2021 |
| Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America LN Carpp, Y Fong, M Bonaparte, Z Moodie, M Juraska, Y Huang, B Price, ... PLoS One 15 (6), e0234236, 2020 | 11 | 2020 |
| Use of an indeterminate range in HIV early infant diagnosis: A systematic review and meta-analysis R Luo, D Boeras, LN Broyles, Y Fong, NY Hsiao, C Kiyaga, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 82 (3), 281-286, 2019 | 11 | 2019 |
| Where have all the children gone? High HIV prevalence in infants attending nutrition and inpatient entry points C Kiyaga, B Urick, Y Fong, C Okiira, N Nabukeera‐Barungi, D Nansera, ... Journal of the International AIDS Society 21 (2), e25089, 2018 | 11 | 2018 |
| Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration D Follmann, MP O’Brien, J Fintzi, MP Fay, D Montefiori, A Mateja, ... Nature Communications 14 (1), 3605, 2023 | 9 | 2023 |
| Borrowing information across populations in estimating positive and negative predictive values Y Huang, Y Fong, J Wei, Z Feng Journal of the Royal Statistical Society Series C: Applied Statistics 60 (5 …, 2011 | 9 | 2011 |
| Frequent development of broadly neutralizing antibodies in early life in a large cohort of children with human immunodeficiency virus A Lucier, Y Fong, SH Li, M Dennis, J Eudailey, A Nelson, K Saunders, ... The Journal of Infectious Diseases 225 (10), 1731-1740, 2022 | 7 | 2022 |
| Forward Stepwise Deep Autoencoder-based Monotone Nonlinear Dimensionality Reduction Methods Y Fong, J Xu Journal of Computational and Graphical Statistics 30 (3), 519-529, 2021 | 7 | 2021 |
| Assessment of immune correlates of protection via controlled vaccine efficacy and controlled risk PB Gilbert, Y Fong, M Carone arXiv preprint arXiv:2107.05734, 2021 | 7 | 2021 |
| Rapid serological tests ineffectively screen for HIV exposure in HIV-positive infants B Urick, Y Fong, C Okiira, N Nabukeera-Barungi, D Nansera, E Ochola, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 77 (3), 331-336, 2018 | 7 | 2018 |
| Kernel-based logistic regression model for protein sequence without vectorialization Y Fong, S Datta, IS Georgiev, PD Kwong, GD Tomaras Biostatistics 16 (3), 480-492, 2015 | 7 | 2015 |
| Calibration weighted estimation of semiparametric transformation models for two‐phase sampling Y Fong, P Gilbert Statistics in medicine 34 (10), 1695-1707, 2015 | 7 | 2015 |
| An efficient Markov Chain Monte Carlo method for mixture models by neighborhood pruning Y Fong, J Wakefield, K Rice Journal of Computational and Graphical Statistics 21 (1), 197-216, 2012 | 7 | 2012 |
| Bayesian mixture modeling using a hybrid sampler with application to protein subfamily identification Y Fong, J Wakefield, K Rice Biostatistics 11 (1), 18-33, 2010 | 7 | 2010 |
| Threshold-based subgroup testing in logistic regression models in two-phase sampling designs Y Huang, J Cho, Y Fong Journal of the Royal Statistical Society Series C: Applied Statistics 70 (2 …, 2021 | 6 | 2021 |
| Vaccine-induced antibody responses modify the association between T-cell immune responses and HIV-1 infection risk in HVTN 505 Y Fong, X Shen, VC Ashley, A Deal, KE Seaton, C Yu, SP Grant, G Ferrari, ... J Infect Dis 217 (8), 1280-1288, 2018 | 6 | 2018 |
| Transformation model choice in nonlinear regression analysis of fluorescence-based serial dilution assays Y Fong, X Yu Statistics in biopharmaceutical research 8 (1), 1-11, 2016 | 6 | 2016 |
| Stochastic interventional vaccine efficacy and principal surrogate analyses of antibody markers as correlates of protection against symptomatic COVID-19 in the COVE mRNA-1273 Trial Y Huang, NS Hejazi, B Blette, LN Carpp, D Benkeser, DC Montefiori, ... Viruses 15 (10), 2029, 2023 | 5 | 2023 |
| Human HIV-1 vaccine induced antibody durability and Env IgG3 responses K Seaton, N Yates, W Williams, L Liao, A deCamp, Y Fong, D Montefiori, ... AIDS RESEARCH AND HUMAN RETROVIRUSES 29 (11), A187-A187, 2013 | 5 | 2013 |
| Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial. medRxiv. 2021: 2021.08. 09.21261290 PB Gilbert, DC Montefiori, A McDermott Reprint requests Address requests for reprints to: Prof Dr Med Julian …, 0 | 5 | |
| Antibody correlates of protection from severe respiratory syncytial virus disease in a vaccine efficacy trial Y Fong, Y Huang, B Borate, LWP van der Laan, W Zhang, LN Carpp, ... Open Forum Infectious Diseases 10 (1), ofac693, 2023 | 4 | 2023 |
| Diagnostic accuracy of dried plasma spot specimens for HIV-1 viral load testing: a systematic review and meta-analysis Y Fong, J Markby, M Andreotti, I Beck, T Bourlet, D Brambilla, L Frenkel, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 89 (3), 261-273, 2022 | 4 | 2022 |
| Immunobridging efficacy of a tetravalent dengue vaccine against dengue and against hospitalized dengue from children/adolescents to adults in highly endemic countries Y Huang, Z Moodie, M Juraska, Y Fong, LN Carpp, L Chambonneau, ... Transactions of The Royal Society of Tropical Medicine and Hygiene 115 (7 …, 2021 | 4 | 2021 |
| Maximum diversity weighting for biomarkers with application in HIV‐1 vaccine studies Z He, Y Fong Statistics in medicine 38 (20), 3936-3946, 2019 | 4 | 2019 |
| Point-of-care CD4 technology invalid result rates in public health care settings across five countries K Lamp, S McGovern, Y Fong, B Abere, A Kebede, G Ayana, A Mulugeta, ... PloS one 14 (7), e0219021, 2019 | 4 | 2019 |
| T-cell based sieve analysis ties HLA A* 02 to vaccine efficacy and IgA-C1 immune correlate in RV144 Thai trial T Hertz, A Gartland, H Janes, S Li, Y Fong, GD Tomaras, D Morris, ... Retrovirology 9, 1-2, 2012 | 4 | 2012 |
| Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials (preprint) D Follmann, J Fintzi, MP Fay, HE Janes, L Baden, H El Sahly, TR Fleming, ... | 3 | 2020 |
| Bayesian inference for generalized linear mixed models Y FONG, H RUE, JON WAKEFIELD Biostatistics 8 (1), 1-27, 2007 | 3 | 2007 |
| Optimizing Deep Learning-Based Segmentation of Densely Packed Cells using Cell Surface Markers S Han, K Phasouk, J Zhu, Y Fong Research Square, 2023 | 2 | 2023 |
| Broadly Neutralizing Antibodies Can Prevent HIV Infection in Foreskin Ex-vivo Explant Infection Models M Lemos, A Naidoo, Y Fong, L Fleming, N Mkhize, R Astronomo, ... AIDS RESEARCH AND HUMAN RETROVIRUSES 32, 39-39, 2016 | 2 | 2016 |
| In men at risk of HIV infection, antibodies can reach the human foreskin epidermis at ratios similar to those in blood MP Lemos, JR Lama, ST Karuna, J Vasylyeva, ME Gamero, S Minaya, ... AIDS RESEARCH AND HUMAN RETROVIRUSES 29 (11), A106-A106, 2013 | 2 | 2013 |
| The inner foreskin of healthy men resembles inflamed epithelium and has features of a compromised skin barrier MP Lemos, ST Karuna, JR Lama, ML Perez, T Goodpaster, J Vasylyeva, ... AIDS RESEARCH AND HUMAN RETROVIRUSES 29 (11), A105-A106, 2013 | 2 | 2013 |
| The RV144 vaccine induced CD4+ T cells producing Th1 and Th2 cytokines with proliferative potential, abstr 0A06. 03. Abstr S DeRosa, N Frahm, OD Defawe, D Carter, EP Thomas, R Smith, ... AIDS Vaccine, 2011 | 2 | 2011 |
| Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine D Follmann, A Mateja, MP Fay, CA Magaret, Y Huang, Y Fong, H Angier, ... Clinical Infectious Diseases, ciae081, 2024 | 1 | 2024 |
| Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial Y Fong, Y Huang, D Benkeser, LN Carpp, G Áñez, W Woo, A McGarry, ... nature communications 14 (1), 1581, 2023 | 1 | 2023 |
| Immune Correlates Analysis of a Single Ad26. COV2. S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial (preprint) Y Fong, AB McDermott, D Benkeser, S Roels, DJ Stieh, A Vandebosch, ... | 1 | 2022 |
Peter B. GilbertMember, Fred Hutchinson Cancer Research Center, and Research Professor, Department of Biostatistics, University of WashingtonVerified email at scharp.org
